SREBP1, an essential regulator of cholesterol and fatty acid metabolism, has recently been shown to mediate circadian remodeling and maladaptive response to the over-nutritional environment of non-alcoholic fatty liver disease, which is a major risk of liver cancer (162). The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.